Cargando…

Metabolomic analysis of human cirrhosis, hepatocellular carcinoma, non-alcoholic fatty liver disease and non-alcoholic steatohepatitis diseases

Metabolome analysis is used to evaluate the characteristics and interactions of low molecular weight metabolites under a specific set of conditions. In cirrhosis, hepatocellular carcinoma, non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatotic hepatitis (NASH) the liver does not funct...

Descripción completa

Detalles Bibliográficos
Autores principales:	Safaei, Akram, Arefi Oskouie, Afsaneh, Mohebbi, Seyed Reza, Rezaei-Tavirani, Mostafa, Mahboubi, Mohammad, Peyvandi, Maryam, Okhovatian, Farshad, Zamanian-Azodi, Mona
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Shaheed Beheshti University of Medical Sciences 2016
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4947130/ https://www.ncbi.nlm.nih.gov/pubmed/27458508

Ejemplares similares

Protein-protein interaction network analysis of cirrhosis liver disease
por: Safaei, Akram, et al.
Publicado: (2016)

Serum Proteomic Profiling of Obsessive-Compulsive Disorder, Washing Subtype: A Preliminary Study
por: Zamanian-Azodi, Mona, et al.
Publicado: (2017)

Protein Interaction Mapping related to Becker Muscular Dystrophy
por: PEYVANDI, Ali Azghar, et al.
Publicado: (2019)

Duchenne Muscular Dystrophy (DMD) Protein-Protein Interaction Mapping
por: REZAEI TAVIRANI, Mostafa, et al.
Publicado: (2017)

Introducing Potential Key Proteins and Pathways in Human Laryngeal Cancer: A System Biology Approach
por: Peyvandi, Hassan, et al.
Publicado: (2018)

Proteomic study of advanced cirrhosis based on HCV to reveal potential biomarkers
por: Safaei, Akram, et al.
Publicado: (2020)

Introducing Serine as Cardiovascular Disease Biomarker Candidate via Pathway Analysis
por: Rezaei Tavirani, Mostafa, et al.
Publicado: (2020)

Incidental finding of non-alcoholic steatohepatitis-cirrhosis
por: Adrian, Therese, et al.
Publicado: (2022)

Evaluation of liver cirrhosis and hepatocellular carcinoma using Protein-Protein Interaction Networks
por: Ehsani Ardakani, Mohammad Javad, et al.
Publicado: (2016)

ANXA2, PRKCE, and OXT are critical differentially genes in Nonalcoholic fatty liver disease
por: Rezaei Tavirani, Mostafa, et al.
Publicado: (2019)

Introducing Transthyretin as a Differentially Expressed Protein in Washing Subtype of Obsessive-Compulsive Disorder
por: Azodi, Mona Zamanian, et al.
Publicado: (2018)

Fluoxetine Regulates Ig Kappa Chain C Region Expression Levels in the Serum of Obsessive-Compulsive Disorder Patients: A proteomic Approach
por: Zamanian Azodi, Mona, et al.
Publicado: (2017)

Investigating the Effects of Ibuprofen on the Gene Expression Profile in Hippocampus of Mice Model of Alzheimer’s Disease through Bioinformatics Analysis
por: Zamanian-Azodi, Mona, et al.
Publicado: (2020)

Hepatocellular carcinoma in non-alcoholic steatohepatitis without cirrhosis
por: Tovo, Cristiane Valle, et al.
Publicado: (2023)

The bioinformatics aspects of gene screening of HT-29, human colon cell line treated with caffeic acid
por: Rezaei-Tavirani, Majid, et al.
Publicado: (2019)

Compound-Protein Interaction Analysis in Condition Following Cardiac Arrest
por: Zamanian Azodi, Mona, et al.
Publicado: (2018)

Identification of the Key Genes of Autism Spectrum Disorder Through Protein-Protein Interaction Network
por: Zamanian Azodi, Mona, et al.
Publicado: (2019)

Obsessive-Compulsive Disorder Interactome Profile Analysis: A Perspective From Molecular Mechanism
por: Zamanian-Azodi, Mona, et al.
Publicado: (2021)

Lavandula angustifolia Effects on Rat Models of Alzheimer’s Disease Through the Investigation of Serum Metabolic Features Using NMR Metabolomics
por: Oskouie, Afsaneh Arefi, et al.
Publicado: (2018)

Investigation of health benefits of cocoa in human colorectal cancer cell line, HT-29 through interactome analysis
por: Zamanian-Azodi, Mona, et al.
Publicado: (2019)

Combined alcoholic and non-alcoholic steatohepatitis
por: Ntandja Wandji, Line Carolle, et al.
Publicado: (2020)

Highlighted role of “IL17 signaling pathway” in gastroesophageal reflux disease
por: Zamanian Azodi, Mona, et al.
Publicado: (2020)

An Animal Model for the Juvenile Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis
por: Marin, Veronica, et al.
Publicado: (2016)

Role of Alcohol Metabolism in Non-Alcoholic Steatohepatitis
por: Baker, Susan S., et al.
Publicado: (2010)

Fructose and Non-Alcoholic Steatohepatitis
por: Roeb, Elke, et al.
Publicado: (2021)

Statins in Non-alcoholic Steatohepatitis
por: Torres-Peña, Jose D., et al.
Publicado: (2021)

Protein Drug Targets of Lavandula angustifolia on treatment of Rat Alzheimer's Disease
por: Zali, Hakimeh, et al.
Publicado: (2015)

Protein-protein interaction network of celiac disease
por: Zamanian Azodi, Mona, et al.
Publicado: (2016)

Serum-based metabolic alterations in patients with papillary thyroid carcinoma unveiled by non-targeted 1H-NMR metabolomics approach
por: Farrokhi Yekta, Reyhaneh, et al.
Publicado: (2018)

Ethanol and Cancer Induce Similar Changes on Protein Expression Pattern of Human Fibroblast Cell
por: Zamanian–Azodi, Mona, et al.
Publicado: (2016)

Gestational Diabetes Mellitus Regulatory Network Identifies hsa-miR-145-5p and hsa-miR-875-5p as Potential Biomarkers
por: Zamanian Azodi, Mona, et al.
Publicado: (2019)

Human Prolactinoma: A View of Protein-Protein Interaction Pattern
por: Zamanian Azodi, Mona, et al.
Publicado: (2018)

Structural and Functional Analysis of Crucial Protein Complex in Basal Cell Skin Carcinoma via Network Construction
por: Zamanian Azodi, Mona, et al.
Publicado: (2018)

Comparative Bioinformatics Characteristic of Bladder Cancer Stage 2 from Stage 4 Expression Profile: A Network-Based Study
por: Zamanian Azodi, Mona, et al.
Publicado: (2018)

Bioinformatics Investigation and Contribution of Other Chromosomes Besides Chromosome 21 in the Risk of Down Syndrome Development
por: Zamanian Azodi, Mona, et al.
Publicado: (2021)

Systematic review: the diagnosis and staging of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis
por: Dowman, J K, et al.
Publicado: (2011)

Role of MicroRNAs in Pathophysiology of Non-alcoholic Fatty Liver Disease and Non-alcoholic Steatohepatitis
por: Iravani, Farzaneh, et al.
Publicado: (2018)

Pleiotropic Effects of Statins in the Light of Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis
por: Ahsan, Farah, et al.
Publicado: (2020)

Increased risk of venous thromboembolism in hospitalized patients with cirrhosis due to non-alcoholic steatohepatitis
por: Stine, Jonathan G., et al.
Publicado: (2018)

Outcomes and potential surrogate markers for future clinical trials of non‐alcoholic steatohepatitis cirrhosis
por: Rivera‐Esteban, Jesús, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_gl1e1l4voq5jntvu8emk7lpe5m